Extracellular proteolytic pathophysiology in the neurovascular unit after stroke

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Neurological Research

• Publication date

  2004-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1179/016164104X3806PMID 15727269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• tPA and proteolysis in the neurovascular unit.

  2004cited by this paper
• The Akt-regulated Forkhead Transcription Factor FOXO3a Controls Endothelial Cell Viability through Modulation of the Caspase-8 Inhibitor FLIP*

  2004cited by this paper
• In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone.

  2004cited by this paper
• Regulation of tight junctions and loss of barrier function in pathophysiology.

  2004cited by this paper
• Induction of Caspase-Mediated Cell Death by Matrix Metalloproteinases in Cerebral Endothelial Cells after Hypoxia—Reoxygenation

  2004cited by this paper
• Role of Matrix Metalloproteinases in Delayed Neuronal Damage after Transient Global Cerebral Ischemia

  2004cited by this paper
• Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.

  2003cited by this paper
• Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator

  2003cited by this paper
• Matrix metalloproteinase–9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy

  2003cited by this paper
• Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells.

  2003cited by this paper
• Pathogenic Aβ induces the expression and activation of matrix metalloproteinase‐2 in human cerebrovascular smooth muscle cells

  2003cited by this paper
• Proteases in brain tumour progression

  2003cited by this paper
• Medicine. Stroke--tPA and the clinic.

  2003cited by this paper
• The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia

  2003cited by this paper
• Essential role for integrin linked kinase in Akt‐mediated integrin survival signaling in hippocampal neurons

  2003cited by this paper
• Interferon-Beta Prevents Cytokine-Induced Neutrophil Infiltration and Attenuates Blood–Brain Barrier Disruption

  2003cited by this paper
• Stroke--tPA and the Clinic

  2003cited by this paper
• Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke

  2003cited by this paper
• Anoikis in the cardiovascular system: known and unknown extracellular mediators.

  2003cited by this paper
• Vampire Bat Salivary Plasminogen Activator (Desmoteplase): A Unique Fibrinolytic Enzyme That Does Not Promote Neurodegeneration

  2003cited by this paper
• Biochemistry of ischemic stroke.

  2003cited by this paper
• Triggers and mediators of hemorrhagic transformation in cerebral ischemia

  2003cited by this paper
• Antiactin-Targeted Immunoliposomes Ameliorate Tissue Plasminogen Activator-Induced Hemorrhage after Focal Embolic Stroke

  2003cited by this paper
• Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke

  2003cited by this paper
• Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed Reperfusion

  2003cited by this paper
• Amyloid β-Protein Stimulates the Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Cerebrovascular Smooth Muscle Cells*

  2003cited by this paper
• Coordinated interaction of the vascular and nervous systems: from molecule- to cell-based approaches.

  2003cited by this paper
• Cerebral Microvessel Responses to Focal Ischemia

  2003cited by this paper
• Neurological diseases: Mechanisms, challenges and opportunities in stroke

  2003cited by this paper
• Inflammatory Mechanisms after Ischemia and Stroke

  2003cited by this paper
• Stroke: molecular mechanisms and potential targets for treatment.

  2003cited by this paper
• Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury.

  2003cited by this paper
• Eicosapentaenoic Acid Protects Endothelial Cells Against Anoikis Through Restoration of cFLIP

  2003cited by this paper
• Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells.

  2003cited by this paper
• Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

  2003cited by this paper
• Correlation of VEGF and Angiopoietin Expression with Disruption of Blood–Brain Barrier and Angiogenesis after Focal Cerebral Ischemia

  2002cited by this paper
• Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells

  2002cited by this paper
• Adjuvant Treatment With Neuroserpin Increases the Therapeutic Window for Tissue-Type Plasminogen Activator Administration in a Rat Model of Embolic Stroke

  2002cited by this paper
• Rosenberg GA. Matrix metalloproteinases in neuroinflammation. GLIA 2002;39(3):279–291.

  2002cited by this paper
• Microplasmin: A Novel Thrombolytic That Improves Behavioral Outcome After Embolic Strokes in Rabbits

  2002cited by this paper
• Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases

  2002cited by this paper
• Matrix metalloproteinases in neuroinflammation

  2002cited by this paper
• Microvascular Basal Lamina Injury after Experimental Focal Cerebral Ischemia and Reperfusion in the Rat

  2002cited by this paper
• Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats

  2002cited by this paper
• Calcium Modulation of Adherens and Tight Junction Function: A Potential Mechanism for Blood-Brain Barrier Disruption After Stroke

  2002cited by this paper
• A Combined Treatment with Tacrolimus (FK506) and Recombinant Tissue Plasminogen Activator for Thrombotic Focal Cerebral Ischemia in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window

  2002cited by this paper
• Hemorrhagic transformation following ischemic stroke: Significance, causes, and relationship to therapy and treatment

  2002cited by this paper
• Tissue Plasminogen Activator Mediates Microglial Activation via Its Finger Domain through Annexin II

  2002cited by this paper
• Characterization of chemokines and their receptors in the central nervous system: physiopathological implications

  2002cited by this paper
• Engagement of Glycoprotein IIb/IIIa (&agr;IIb&bgr;3) on Platelets Upregulates CD40L and Triggers CD40L-Dependent Matrix Degradation by Endothelial Cells

  2002cited by this paper
• Reciprocal actions of NCAM and tPA via a Ras-dependent MAPK activation in rat hippocampal neurons.

  2002cited by this paper
• S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death

  2002cited by this paper
• Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain.

  2002cited by this paper
• Current and future therapeutic strategies to target inflammation in stroke.

  2002cited by this paper
• Secretion of Matrix Metalloproteinase-2 and -9 after Mechanical Trauma Injury in Rat Cortical Cultures and Involvement of MAP Kinase

  2002cited by this paper
• Tight junctions of the blood-brain barrier: development, composition and regulation.

  2002cited by this paper
• Integrin signaling via the PI3‐kinase–Akt pathway increases neuronal resistance to glutamate‐induced apoptosis

  2001cited by this paper
• Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice.

  2001cited by this paper
• Matrix Metalloproteinase Inhibition Prevents Oxidative Stress-Associated Blood–Brain Barrier Disruption after Transient Focal Cerebral Ischemia

  2001cited by this paper
• Programmed Cell Death in Cerebral Ischemia

  2001cited by this paper
• Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia

  2001cited by this paper
• Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier

  2001cited by this paper
• Astrocytes attenuate oligodendrocyte death in vitro through an α6 integrin‐laminin–dependent mechanism

  2001cited by this paper
• Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice.

  2001cited by this paper
• Vascular growth factors in cerebral ischemia

  2001cited by this paper
• Disruption of focal adhesions mediates detachment during neuronal apoptosis

  2001cited by this paper
• Rapid Loss of Microvascular Integrin Expression during Focal Brain Ischemia Reflects Neuron Injury

  2001cited by this paper
• LRP: a multifunctional scavenger and signaling receptor.

  2001cited by this paper
• Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins

  2001cited by this paper
• Elements of cerebral microvascular ischaemia.

  2001cited by this paper
• Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis.

  2001cited by this paper
• Matrix Attachment Regulates FAS-Induced Apoptosis in Endothelial Cells

  2001cited by this paper
• The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling

  2001cited by this paper
• ICAM-1-Coupled Cytoskeletal Rearrangements and Transendothelial Lymphocyte Migration Involve Intracellular Calcium Signaling in Brain Endothelial Cell Lines1

  2000cited by this paper
• Inflammatory Mediators of Cerebral Endothelium: A Role in Ischemic Brain Inflammation

  2000cited by this paper
• beta1 integrin antagonism on adherent, differentiated human neuroblastoma cells triggers an apoptotic signaling pathway.

  2000cited by this paper
• Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94

  2000cited by this paper
• Matrix metalloproteinases: not-so-innocent bystanders in heart failure.

  2000cited by this paper
• Advances in the vascular pathophysiology of ischemic stroke.

  2000cited by this paper
• Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke

  2000cited by this paper
• VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain.

  2000cited by this paper
• Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.

  2000cited by this paper
• Overexpression of Copper and Zinc Superoxide Dismutase in Transgenic Mice Prevents the Induction and Activation of Matrix Metalloproteinases after Cold Injury-Induced Brain Trauma

  2000cited by this paper
• Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.

  2000cited by this paper
• Intracerebral administration of interleukin-1β and induction of inflammation, apoptosis, and vasogenic edema

  2000cited by this paper
• Intracerebral administration of interleukin-1beta and induction of inflammation, apoptosis, and vasogenic edema.

  2000cited by this paper
• Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion.

  1999cited by this paper
• Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics

  1999cited by this paper
• [Amyloid beta protein].

  1999cited by this paper
• Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO.

  1999cited by this paper
• Molecular cloning and expression of the rat monocyte chemotactic protein-3 gene: a possible role in stroke.

  1999cited by this paper
• VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain.

  1999cited by this paper
• Thrombolysis in acute ischemic stroke: controlled trials and clinical experience.

  1999cited by this paper
• Stobadine protects against ischemia-reperfusion induced morphological alterations of cerebral microcirculation in dogs.

  1999cited by this paper
• Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO.

  1999cited by this paper
• Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway.

  1999cited by this paper
• Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia

  1999cited by this paper
• Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo.

  1998cited by this paper
• The expression of P- and E-selectins in three models of middle cerebral artery occlusion.

  1998cited by this paper
• Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke

  1998cited by this paper

• Brain-derived endothelial cells are neuroprotective in a chronic cerebral hypoperfusion mouse model

  2024cites this paper
• Increasing reproducibility in preclinical stroke research: the correlation of immunofluorescence intensity measurements and Western blot analyses strongly depends on antibody clonality and tissue pre-treatment in a mouse model of focal cerebral ischemia

  2023cites this paper
• CSF lipocalin-2 increases early in subarachnoid hemorrhage are associated with neuroinflammation and unfavorable outcome

  2021cites this paper
• Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy

  2020cites this paper
• The Effects of Intelectin-1 on Antioxidant and Angiogenesis in HUVECs Exposed to Oxygen Glucose Deprivation

  2019cites this paper
• Intracerebroventricular Delivery of Recombinant NAMPT Deters Inflammation and Protects Against Cerebral Ischemia

  2019cites this paper
• Neuroprotection and vasculoprotection using genetically targeted protease-ligands.

  2019cites this paper
• Acute- and late-phase matrix metalloproteinase (MMP)-9 activity is comparable in female and male rats after peripheral nerve injury

  2018cites this paper
• Chemokines and Proteolysis: Implications for Stem Cell Dynamics in Ischemic Stroke

  2018cites this paper
• Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research

  2018cites this paper
• The High Cost of Stroke and Stroke Cytoprotection Research

  2016cites this paper
• Regulation of Dipeptidyl Peptidase IV in the Post-stroke Rat Brain and In Vitro Ischemia: Implications for Chemokine-Mediated Neural Progenitor Cell Migration and Angiogenesis

  2016cites this paper
• Minocycline induces protective autophagy in vascular endothelial cells exposed to an in vitro model of ischemia/reperfusion-induced injury

  2015cites this paper
• Alterations of the Blood-Brain Barrier in Post-Traumatic Epilepsy

  2015cites this paper
• Inhibition of connexin43 improves functional recovery after ischemic brain injury in neonatal rats

  2015cites this paper
• Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers

  2014cites this paper
• Rapamycin induces of protective autophagy in vascular endothelial cells exposed to oxygen-glucose deprivation.

  2014cites this paper
• Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes.

  2014cites this paper
• Role of matrix metalloproteinases in animal models of ischemic stroke.

  2014cites this paper
• The Inflammatory Response to Ischemic Acute Renal Injury

  2013cites this paper
• Glutamate treatment and preconditioning differently affect cathepsin B release and intracellular proteases in primary cultures of cerebellar granular cells

  2013cites this paper
• Inhibition of Matrix Metalloproteinases-2/-9 Transiently Reduces Pre-Oligodendrocyte Loss during Lipopolysaccharide- but Not Tumour Necrosis Factor-alpha-Induced Inflammation in Fetal Ovine Glial Culture

  2013cites this paper
• Astrocytes and Pericytes Differentially Modulate Blood—Brain Barrier Characteristics during Development and Hypoxic Insult

  2011cites this paper
• Magnetic Resonance Characterization of Ischemic Tissue Metabolism

  2011cites this paper
• Metalloproteinase and stroke infarct size: role for anti‐inflammatory treatment?

  2010cites this paper
• A neural stem/progenitor cell based approach for brain repair

  2010cites this paper
• Annexin A2 Combined with Low-Dose tPA Improves Thrombolytic Therapy in a Rat Model of Focal Embolic Stroke

  2010cites this paper
• Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases

  2010cites this paper
• A novel quantification of blood-brain barrier damage and histochemical typing after embolic stroke in rats.

  2010cites this paper
• DL-3-n-butylphthalide protects endothelial cells against oxidative/nitrosative stress, mitochondrial damage and subsequent cell death after oxygen glucose deprivation in vitro.

  2009cites this paper
• In Vivo Near-Infrared Fluorescence Imaging of Matrix Metalloproteinase Activity after Cerebral Ischemia

  2009cites this paper
• The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus.

  2009cites this paper
• Multiphasic roles for matrix metalloproteinases after stroke.

  2008cites this paper
• CHAPTER 90 – The Inflammatory Response to Ischemic Acute Renal Injury

  2008cites this paper
• Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy.

  2008cites this paper
• Mechanisms and markers for hemorrhagic transformation after stroke.

  2008cites this paper
• Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery

  2008influential citation
• Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve.

  2007cites this paper
• Coregulation of light neurofilament mRNA by poly(A)-binding protein and aldolase C: implications for neurodegeneration.

  2007cites this paper
• Role of c‐Jun N‐terminal kinase in early brain injury after subarachnoid hemorrhage

  2007cites this paper
• The Neurovascular Unit and the Key Role of Astrocytes in the Regulation of Cerebral Blood Flow

  2006cites this paper
• Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group

  2006cites this paper
• Myelin Formation during Development of the CNS Is Delayed in Matrix Metalloproteinase-9 and -12 Null Mice

  2006cites this paper
• Advances in stroke neuroprotection: hyperoxia and beyond.

  2005cites this paper
• Mechanisms of neuronal degeneration after ischemic stroke – Emerging targets for novel therapeutic strategies

  2005cites this paper